← Leaderboards
Taylor A Doherty
Va San Diego Healthcare System
$5,312,468
Attributed
$5,312,468
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $812.9K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,312,468 · 4
VA$0 · 1
By mechanism
R01$2,321,750 · 1
U19$1,554,442 · 1
K24$774,776 · 1
K08$661,500 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Therapeutic Target”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$399,079,477
- Judith S. Currier · University Of California Los Angeles$274,271,371
- Peter C Adamson · National Childhood Cancer Foundation$268,343,924
- Barbara Driver · Westat, Inc.$175,154,472
Research focus
Therapeutic TargetAsthmaAirway InflammationIn VitroIn VivoResponseCytokineLungInflammatorySamplingMediatingLymphoid CellAllergensInflammationPathway InteractionsEosinophilPeripheral BloodCellsLung InflammationProductionAdoptive TransferInterleukin-13BloodMucous Body Substance
Grant awards (24)
Mentoring patient-oriented researchers in inflammatory airway disease$193,694
K24 · FY2025 · AI · contact PI
Targeting pathogenic innate lymphoid cells in airway disease$0
I01 · FY2025 · VA · contact PI
Mentoring patient-oriented researchers in inflammatory airway disease$193,694
K24 · FY2024 · AI · contact PI
Roles of STING and innate lymphoid cell plasticity in severe asthma$0
I01 · FY2024 · VA · contact PI
Mentoring patient-oriented researchers in inflammatory airway disease$193,694
K24 · FY2023 · AI · contact PI
Roles of STING and innate lymphoid cell plasticity in severe asthma$0
I01 · FY2023 · VA · contact PI
Mentoring patient-oriented researchers in inflammatory airway disease$193,694
K24 · FY2022 · AI · contact PI
Roles of STING and innate lymphoid cell plasticity in severe asthma$0
I01 · FY2022 · VA · contact PI
Roles of STING and innate lymphoid cell plasticity in severe asthma$0
I01 · FY2021 · VA · contact PI
ALCAM/CD6 interactions in airway inflammation and remodeling$310,000
U19 · FY2020 · AI · contact PI
RBM3 regulation of type 2 innate lymphoid cells in allergic inflammation$461,600
R01 · FY2019 · AI · contact PI
ALCAM/CD6 interactions in airway inflammation and remodeling$318,926
U19 · FY2019 · AI · contact PI
RBM3 regulation of type 2 innate lymphoid cells in allergic inflammation$461,600
R01 · FY2018 · AI · contact PI
ALCAM/CD6 interactions in airway inflammation and remodeling$351,331
U19 · FY2018 · AI · contact PI
RBM3 regulation of type 2 innate lymphoid cells in allergic inflammation$461,600
R01 · FY2017 · AI · contact PI
ALCAM/CD6 interactions in airway inflammation and remodeling$310,000
U19 · FY2017 · AI · contact PI
RBM3 regulation of type 2 innate lymphoid cells in allergic inflammation$461,600
R01 · FY2016 · AI · contact PI
ALCAM/CD6 interactions in airway inflammation and remodeling$264,185
U19 · FY2016 · AI · contact PI
RBM3 regulation of type 2 innate lymphoid cells in allergic inflammation$475,350
R01 · FY2015 · AI · contact PI
OX40/OX40L interactions in allergen-induced airway inflammation and remodeling$132,300
K08 · FY2014 · AI · contact PI
OX40/OX40L interactions in allergen-induced airway inflammation and remodeling$132,300
K08 · FY2013 · AI · contact PI
OX40/OX40L interactions in allergen-induced airway inflammation and remodeling$132,300
K08 · FY2012 · AI · contact PI
OX40/OX40L interactions in allergen-induced airway inflammation and remodeling$132,300
K08 · FY2011 · AI · contact PI
OX40/OX40L interactions in allergen-induced airway inflammation and remodeling$132,300
K08 · FY2010 · AI · contact PI